| Date Filed | Type | Description |
| 10/03/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $0.8904, valued at
$2k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $1.2, valued at
$2.7k
|
|
| 06/01/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $1.21, valued at
$2.7k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 2,239 shares
@ $1.61, valued at
$3.6k
|
|
| 03/15/2023 |
4
| Rosa David A (Director) has filed a Form 4 on BIOTRICITY INC.|
Txns:
| Granted 75,930 options to buy
@ $1.94, valued at
$147.3k
|
|
| 02/07/2023 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Paid exercise price by delivering 53,750 shares
@ $1.47, valued at
$79k
|
|
| 01/30/2023 |
4
| Rosa David A (Director) has filed a Form 4 on Healthcare Triangle, Inc.|
Txns:
| Granted 1 options to buy
@ $0.349, valued at
$0.3 |
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/09/2022 |
4
| Rosa David A (Director) has filed a Form 4 on BIOTRICITY INC.|
Txns:
| Granted 31,106 options to buy
@ $2.4, valued at
$74.7k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
5
| Rosa David A (Director) has filed a Form 5 on Healthcare Triangle, Inc. |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
3
| Rosa David A (Director) has filed a Form 3 on Healthcare Triangle, Inc. |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2021 |
4
| Rosa David A (Director) has filed a Form 4 on BioRestorative Therapies, Inc.|
Txns:
| Granted 10,490 options
@ $13.5, valued at
$141.6k
|
|
| 11/08/2021 |
3
| Rosa David A (Director) has filed a Form 3 on BioRestorative Therapies, Inc. |
| 10/13/2021 |
4
| Rosa David A (Director) has filed a Form 4 on BIOTRICITY INC.|
Txns:
| Sold 17,228 shares
@ $3.0833, valued at
$53.1k
Sold 9,481 shares
@ $3.1994, valued at
$30.3k
Sold 3,318 shares
@ $3.05, valued at
$10.1k
|
|
| 10/07/2021 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 83,333 options to buy
@ $5.97, valued at
$497.5k
|
|
| 09/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 1,000,000 options to buy
@ $1.99, valued at
$2M
|
|
| 04/09/2020 |
4
| Rosa David A (Director) has filed a Form 4 on BIOTRICITY INC.|
Txns:
| Granted 367,647 options to buy
@ $0.98, valued at
$360.3k
|
|
| 11/07/2019 |
4
| Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 500,000 options to buy
@ $2.14, valued at
$1.1M
|
|
| 08/28/2019 |
3
| Rosa David A (Director) has filed a Form 3 on BIOTRICITY INC. |
| 07/26/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/03/2015 |
4
| Rosa David A (CEO) has filed a Form 4 on Sunshine Heart, Inc.|
Txns:
| Paid exercise price by delivering 5,226 shares
@ $3.11, valued at
$16.3k
|
|
| 07/06/2015 |
4
| Rosa David A (CEO) has filed a Form 4 on Sunshine Heart, Inc.|
Txns:
| Paid exercise price by delivering 5,226 shares
@ $3.29, valued at
$17.2k
|
|
| 06/03/2015 |
4
| Rosa David A (CEO) has filed a Form 4 on Sunshine Heart, Inc.|
Txns:
| Paid exercise price by delivering 5,226 shares
@ $4.38, valued at
$22.9k
|
|
| 05/04/2015 |
4
| Rosa David A (CEO) has filed a Form 4 on Sunshine Heart, Inc.|
Txns:
| Paid exercise price by delivering 5,226 shares
@ $4.28, valued at
$22.4k
|
|
| 04/02/2015 |
4
| Rosa David A (CEO) has filed a Form 4 on Sunshine Heart, Inc.|
Txns:
| Paid exercise price by delivering 5,226 shares
@ $4.26, valued at
$22.3k
|
|
| 03/02/2015 |
4
| Rosa David A (CEO) has filed a Form 4 on Sunshine Heart, Inc.|
Txns:
| Paid exercise price by delivering 5,226 shares
@ $5.75, valued at
$30k
|
|
|